What is the appropriate dose of domperidone syrup for a 10 kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Domperidone Dosing for a 10 kg Child

For a 10 kg child, the appropriate dose of domperidone syrup is 3-5 mg (0.3-0.5 mg/kg) given three times daily before meals, not exceeding 30 mg total per day.

Dosing Calculation

The established pediatric dosing for domperidone is 0.3 mg/kg given three times daily 1. For a 10 kg child, this translates to:

  • Single dose: 3 mg (0.3 mg/kg × 10 kg)
  • Frequency: Three times daily before meals 1
  • Maximum daily dose: 9 mg (well below the 30 mg/day safety limit)

Some studies have used slightly higher doses of 0.5 mg/kg per dose for antiemetic purposes 2, which would equal 5 mg per dose for a 10 kg child, though the lower 0.3 mg/kg dose is more commonly recommended for chronic use 1.

Critical Safety Considerations

Age and Duration Restrictions

  • Domperidone should ideally be limited to children over 12 years of age per current regulatory guidance 3
  • Maximum treatment duration: 7 days 4, 5
  • Off-label use in younger children requires careful risk-benefit assessment 3

Cardiac Monitoring Requirements

QTc prolongation is a significant concern, particularly in infants and young children 6:

  • Baseline ECG should be obtained before initiating therapy 6
  • QTc prolongation >30 ms has been documented in infants receiving 1.3 mg/kg/day 6
  • Monitor for cardiac symptoms (palpitations, syncope) 7
  • Avoid in patients with pre-existing cardiac conditions or electrolyte abnormalities 7

Contraindications and Drug Interactions

  • Avoid concurrent use with QTc-prolonging medications 5
  • Contraindicated with significant cardiac comorbidities 4
  • Screen for medications that may interact with domperidone 5

Clinical Efficacy Context

Evidence for domperidone efficacy in pediatric gastroenteritis is limited. A large multicenter trial found that domperidone was not effective for symptomatic treatment of vomiting during acute gastroenteritis compared to ondansetron or placebo 2. However, domperidone has shown efficacy in:

  • Chronic pediatric vomiting and regurgitation (superior to metoclopramide and placebo) 1
  • Chemotherapy-induced nausea at doses of 0.7 mg/kg per dose 8

Practical Administration

If domperidone syrup is prescribed despite safety concerns:

  • Administer 30 minutes before meals 1
  • Ensure proper dilution if using injectable formulation to avoid pain 8
  • Reassess need for continuation after 7 days maximum 5
  • Document clear indication for off-label use in children under 12 years 3

Common Pitfall

The most significant prescribing error is exceeding the 7-day treatment duration (occurred in 84% of cases in one study) and use in patients over 60 years when applied to adult populations 4. In pediatrics, the primary concern is inadequate cardiac monitoring when using domperidone in infants and young children 6.

References

Research

Drugs in Focus: Domperidone.

Journal of pediatric gastroenterology and nutrition, 2023

Research

Domperidone prescribing patterns in pediatric patients before and after safety warning in South Korea.

International journal of clinical pharmacology and therapeutics, 2020

Research

[Proarrhythmic effects of domperidone in infants: a systematic review].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014

Research

Cardiac safety and clinical efficacy of high-dose domperidone for long-term treatment of gastroparesis symptoms.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022

Research

Domperidone as an antiemetic in paediatric oncology.

Cancer chemotherapy and pharmacology, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.